In vitro biological activity screening of Lycopodium complanatum L. ssp. chamaecyparissus (A. Br.) Döll

Natural Product Research

Volumn 23, Issue 6, 2009, Pages 514-526

  Orhan, Ilkay ^a   Özçelik, Berrin ^a   Aslan, Sinem ^b   Kartal, Murat ^b   Karaoglu, Taner ^b   Şener, Bilge ^a   Terzioglu, Salih ^c   Iqbal Choudhary, M ^d  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^d UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Alkaloid; Bioactivity; GC MS; Lycopodiaceae; Lycopodium complanatum spp. chamaecyparissus

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETYLCHOLINESTERASE; ACICLOVIR; ALKALOID DERIVATIVE; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; BUTYLATED HYDROXYANISOLE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; FLUCONAZOLE; GALANTAMINE; KETOCONAZOLE; LEVOFLOXACIN; LYCOPODINE; LYCOPODIUM COMPLANATUM CHAMAECYPARISSUS EXTRACT; OFLOXACIN; OSELTAMIVIR; PLANT EXTRACT; SCAVENGER; UNCLASSIFIED DRUG; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; BIPHENYL DERIVATIVE; PICRIC ACID;

ACTINOBACTER BAUMANNII; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CAPILLARY GAS CHROMATOGRAPHY; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ESCHERICHIA COLI; HERPES SIMPLEX VIRUS; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LYCOPODIACEAE; LYCOPODIUM COMPLANATUM CHAMAECYPARISSUS; MASS SPECTROMETRY; MEDICINAL PLANT; NONHUMAN; PARAINFLUENZA VIRUS 3; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC); VERO CELL; ANIMAL; BACTERIUM; CATTLE; CELL LINE; CERCOPITHECUS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; LYCOPODIUM; MASS FRAGMENTOGRAPHY; METABOLISM;

BACILLUS SUBTILIS; BOVINAE; CANDIDA ALBICANS; DNA VIRUSES; ESCHERICHIA COLI; FUNGI; HERPES; KLEBSIELLA PNEUMONIAE; LYCOPODIACEAE; LYCOPODIUM COMPLANATUM; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RNA VIRUSES; SIMPLEXVIRUS; STAPHYLOCOCCUS AUREUS;

ACETYLCHOLINESTERASE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; BACTERIA; BIPHENYL COMPOUNDS; BUTYRYLCHOLINESTERASE; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; CHOLINESTERASE INHIBITORS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LYCOPODIUM; PARAINFLUENZA VIRUS 3, HUMAN; PICRATES; PLANT EXTRACTS; SIMPLEXVIRUS; TURKEY;

EID: 67049145625     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802163743     Document Type: Article

References (25)

1. Ahmed, E., Nawaz, S.A., Malik, A., & Choudhary, M.I. (2006). Isolation and cholinesteraseinhibition studies of sterols from Haloxylon recurvum. Bioorganic and Medicinal Chemistry Letters, 16, 573-580. (Pubitemid 43014839)
2. Atta-ur-Rahman, Akhtar, M.N., Choudhary, M.I., Tsuda, Y., Şener, B., Khalid, A., et al. (2002). New steroidal alkaloids from Fritillaria imperialis and their cholinesterase inhibiting activities. Chemical and Pharmaceutical Bulletin, 50, 1013-1016. (Pubitemid 41702056)
3. Atta-ur-Rahman, Parveen, S., Khalid, A., Farooq, A., & Choudhary, M.I. (2001). Acetyl and butyrylcholinesterase-inhibiting triterpenoidal alkaloids from Buxus papillosa. Phytochemistry, 58, 963-968. (Pubitemid 33086224)
4. Bloor, S.J. (1995). A survey of extracts of New Zealand indigenous plants for selected biological activities. New Zealand Journal of Botany, 33, 523-540.
5. Dalimov, D.N., Abduvakhabov, A.A., Aslanov, K.A., Godovikov, N.N., & Sadykov, A.S. (1978). Anticholinesterase properties of N-[β- (dialkoxyphosphinylmercaptoethyl)] decahydroquinolines and their methiodies. Russian Chemical Bulletin, 27, 2324-2329.
6. Davis, P.H., & Cullen, J. (1984). Lycopodium L. In P.H. Davis (Ed.), Flora of Turkey and the east Aegean Islands (Vol. 1, pp. 88-90). Edinburgh: Edinburgh University Press.
7. Ellman, G.L., Courtney, K.D., Andres, V., & Featherstone, R.M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88-95.
8. Foster, S. (1989). Huperzia: hype or hope? HerbalGram, 18/19, 21-23.
9. Frey, H.R., & Liess, B. (1971). Vermehrungskinetik und Verwendbarkeit eines stark zytopathogenen VD-MD virusstammes fü r diagnostische Untersuchungen mit der mikrotiter-methode. Journal of Veterinary Medicine, Series B, 18, 61-71.
10. Iwata, N., Higuchi, M., & Saido, T.C. (2005). Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacology and Therapeutics, 108, 129-148. (Pubitemid 41527082)
11. Karcmaz, A. (1998). Anticholinesterases: Dramatic aspects of their use and misuse. Neurochemistry International, 32, 401-411.
12. Kobayashi, J., Hirasawa, Y., Yoshida, N., & Morita, H. (2000). Complanadine A, a new dimeric alkaloid from Lycopodium complanatum. Tetrahedron Letters, 41, 9069-9073. (Pubitemid 30840941)
13. Lawrence, G.H.M. (1989). Taxonomy of vascular plants (pp. 337-338). New York: MacMillan Publishing Co. Inc.
14. Lee, S.K., Zakaria, H., Chung, H., Luyengi, L., Gamez, E.J.C., Mehta, R.J., et al. (1998). Evaluation of the antioxidant potential of natural products. Combinational Chemistry and High Throughput Screening, 1, 35-46. (Pubitemid 128541767)
15. Liu, J.S., Zhu, Y.L., Yu, C.M., Zhou, Y.Z., Han, Y.Y., Wu., F.W., et al. (1986). The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Canadian Journal of Chemistry, 64, 837-839.
16. Morita, H., Ishiuchi, K., Haganuma, A., Hoshino, T., Obara, Y., Nakahata, N., et al. (2005). Complanadine B, obscurumines A and B, new alkaloids from two species of Lycopodium. Tetrahedron, 61, 1955-1960. (Pubitemid 40203194)
17. National Committee for Clinical Laboratory Standards. (1996). Method for broth dilution antifungal susceptibility testing yeast, approved standard, M27-A, 15, 10. Tucson: NCCLS, VA Medical Center.
18. National Committee for Clinical Laboratory Standards. (2002) Methods for dilution antimicrobial susceptibility tests bacteria that grow aerobically (3rd ed.), approved standard. NCCLS document M100-S12. Wayne, PA, USA: NCCLS.
19. O'Neill, M.F. (2005). Difficult times for Alzheimer's treatments. Drug Discovery Today, 10, 1333-1335.
20. Ortega, M.G., Agnese, A.M., & Cabrera, J.L. (2004). Anticholinesterase activity in an alkaloid extract of Huperzia saururus. Phytomedicine, 11, 539-543. (Pubitemid 39312631)
21. Ö zçelik, B., Aslan, M., Orhan, I., & Karaoglu, T. (2005). Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera L. Microbiological Research, 160, 159-164.
22. Ö zçelik, B., Citak, S., Cesur, S., Abbasoglu, U., & Icli, F. (2004a). In vitro susceptibility of Candida spp. to antifungal agents. Drug Metabolism and Drug Interactions, 20, 5-8.
23. Özçelik, B., Küsmenoglu, Ş ., Türköz, S., & Abbasoglu, U. (2004b). Antimicrobial activities of some plants from the Apiaceae family. Pharmaceutical Biology, 42, 526-528.
24. Tlegenov, R.T., Khaitbaev, K., Tilyabaev, E., Dalimov, D.N., Abduvakhabov, A.A., & Uteniyazov, K.U. (1991). Synthesis and anticholinesterase properties of new derivatives of lupinine and epilupinine. Chemistry of Natural Products, 27, 55-57.
25. Zhang, Z., El-Sohly, H.N., Jacob, M.R., Pasco, D.S., Walker, L.A., & Clark, A.M. (2002). Natural products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cernuum. Journal of Natural Products, 65, 979-985. (Pubitemid 34827482)